Sernova Cell Pouch

COMBINATION_PRODUCT2 trials

Sponsors

University of Alberta, Sernova Biotherapeutics Inc.

Conditions

Type 1 Diabetes MellitusType I Diabetes

Phase 1

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

TerminatedNCT01652911

University of AlbertaType I Diabetes

Start: 2012-06-30End: 2016-03-31Updated: 2022-05-11

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Active, not recruitingNCT03513939

Sernova Biotherapeutics Inc.Type 1 Diabetes Mellitus

Start: 2019-02-07End: 2026-10-01Target: 17Updated: 2026-02-25